Sonova Stock - AGM approves higher dividend payout

Sonova shareholders have approved a higher CHF 4.70 dividend at the 41st annual general meeting, underscoring the Swiss hearing care group's cash-generation profile. A look at the payout decision, current operations and where the stock stands now.

Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 19:23 UTC. Details in the imprint.

Sonova (CH0012549785) held its 41st annual general meeting in Switzerland and secured shareholder approval for a higher cash dividend of CHF 4.70 per share for the 2025-26 financial year. According to an AGM summary dated 06/16/2026, the payout marks a new record level and reflects robust earnings and cash flow.

What the AGM decided

The AGM on 06/16/2026 approved a cash dividend of CHF 4.70 per share, up 6.8% from the previous year, when CHF 4.40 was distributed. This corresponds to a total payout of around CHF 262 million to shareholders, according to German-language financial coverage of the meeting.

The higher distribution follows another year of growth in Sonova's core hearing care activities and underscores the group's policy of gradually raising shareholder remuneration when earnings permit. Shareholders also re-elected the existing board members and confirmed the chair, while adding new directors to the supervisory body.

Operations and strategic backdrop

Sonova's core business spans hearing aids, audiological care networks and cochlear implants, with management aiming for above-market growth through innovation and geographic expansion. In its most recent earnings call, the company highlighted strong wholesale momentum and expanding margins as key drivers of its medium-term ambitions.

The global market for hearing aid devices was valued at about $6.69 billion in 2023 and is expected to grow at a compound annual rate of roughly 5.5% through 2030, driven by aging populations and greater awareness of hearing health. Against this backdrop, Sonova continues to invest in new platforms, wireless connectivity and rechargeable technologies to defend and extend its market position.

How Sonova makes its money

Sonova generates most of its revenue from hearing instruments sold under brands such as Phonak, including products like the Phonak Audéo Lumity family of receiver-in-canal hearing aids. Additional income comes from audiological care clinics and cochlear implant systems, making the group a diversified hearing care platform rather than a pure device manufacturer.

Where the stock trades today

Sonova shares (CH0012549785) trade on the SIX Swiss Exchange under the ticker SOON at CHF 193.40 as of 06/16/2026, 17:30 CET.

Key facts on Sonova stock

• Company: Sonova Holding AG
• ISIN: CH0012549785
• WKN: 125497
• Ticker: SOON
• Venue: SIX Swiss Exchange
• Price (as of 06/16/2026, 17:30 CET): 193.40 CHF
• Market cap: 11,94 billion CHF (as of 06/16/2026)
• Sector / Industry: Health Care - Hearing aid devices and audiological services
• Index membership: Swiss Performance Index (SPI)
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.